Igor M Tereshin

Title: Innovations of Igor M. Tereshin in Fibrinolysin Derivatives

Introduction

Igor M. Tereshin, based in Saint-Petersburg, Russia, is an accomplished inventor with a focus on biochemical innovations. He has developed a significant patent that contributes to advancements in medical treatments involving fibrinolysin.

Latest Patents

Tereshin holds one patent titled "Dextran derivative of fibrinolysin." This patent details a method for preparing a polysaccharide derivative of fibrinolysin. The innovative process involves reacting fibrinolysin with dextran dialdehyde, which has a molecular mass ranging from 20,000 to 110,000. The reaction is conducted at a pH between 8.0 and 9.5, within a temperature range of 5°C to 30°C, resulting in the formation of a covalent bond. The derivative produced from this process is then further reduced with sodium borohydride and isolated, presenting a unique solution for medical applications.

Career Highlights

Igor M. Tereshin is affiliated with the Vsesoyuzny Kardiologichesky Nauchny Tsentr (All-Union Cardiological Scientific Center). His work at this prestigious institution underscores his commitment to advancing cardiac health through innovative research and development. His focused contributions continue to impact the field of cardiology positively.

Collaborations

Throughout his career, Tereshin has collaborated with notable professionals in the medical research field, including Evgeny I. Chazov and Vladimir N. Smirnov. These collaborations reflect his integration into a network of esteemed colleagues, advancing the study of fibrinolysis and its applications.

Conclusion

Igor M. Tereshin is an influential figure in the field of biochemical innovation, particularly known for his work on fibrinolysin derivatives. His patent and collaborations highlight the importance of continued research and development in medical science. As he progresses in his career, his contributions are likely to play a crucial role in shaping future medical therapies.